Volume 15

  • No. 4 December 2021
    In this issue...

    • Building partnerships to fight antimicrobial resistance

    • Exploring the rare disease deals of 2021

    • A spotlight on inflammation and allergies

  • No. 3 September 2021
    In this issue...

    • Biopharma M&A deals bounce back

    • New immune checkpoint targets show promise

    • Exploring the cell and gene therapy landscape

    • Bispecific antibody partnerships tackling oncology

  • No. 2 June 2021
    In this issue...

    • Unraveling dealmaking in 2021

    • New vaccine technologies take centre stage

    • Central nervous system disorders: the top tens

    • Exploring innovation in ophthalmic diseases

    • Fast-tracking drug development with artificial intelligence

  • No. 1 March 2021
    In this issue...

    • Dealmaking trends in oncology

    • The target driving partnerships in hematology